Natalia Novikova spoke about PJSC Kraspharma in Krasnoyarsk, which has become one of the flagships of Russia’s pharmaceutical industry. She addressed pressing issues facing both the pharmaceutical sector and the national market, and shared her vision for overcoming these challenges. Particular emphasis was placed on the importance of full-cycle drug production.

According to Ms. Novikova, there is an urgent need to develop a robust market for active pharmaceutical ingredients (APIs) produced in Russia and EAEU countries. To achieve this, she believes the industry must focus on building large-scale domestic API manufacturing facilities.

She emphasized that the stable, forward-looking growth of PJSC Kraspharma is the result of a consistent strategy aimed at expanding production capacities in line with global standards, while also broadening the company’s product portfolio.

Read the full interview